Healio (8/7, Demko) reports investigators “observed no long-term adverse effects in a small sample of patients with severe and treatment-resistant mood disorders who received ketamine infusions as clinical treatment.” The findings of the 54-patient study were published online in the Journal of Clinical Psychiatry. (SOURCE: APA Headlines)